Literature DB >> 26195117

[Children exposed to multidrug-resistant tuberculosis: How should we manage? Analysis of 46 child contacts and review of the literature].

G Catho1, A Sénéchal2, A-S Ronnaux-Baron3, F Valour4, T Perpoint4, A Bouaziz4, O Dumitriescu5, P Reix6, C Pedone6, F Ader7.   

Abstract

INTRODUCTION: Tuberculosis-related morbidity and mortality remain important. Emergence and diffusion of multidrug-resistance tuberculosis (MDR-TB) is a global public health concern. Cases of MDR-TB in children are a sentinel event indicating the spread of a mycobacterial strain within a community. Latent TB precedes MDR-TB and screening and follow-up of contact individuals are key points of TB infection control.
METHODS: We performed the case-investigation of 20 adult cases of MDR-TB managed in our institution.
RESULTS: Forty-six pediatric contact individuals were identified. A high proportion of these children were lost to follow-up (80% at 12 months), showing that monitoring this reservoir population with migrant history is challenging. Five (11%) children presented a secondary infection: one child was diagnosed with active TB infection (positive tuberculin skin test associated with abnormalities on chest computer tomography [CT] scan). Four children were diagnosed with latent TB infection (isolated positive tuberculin skin test with normal CT scan). Two of these children received a treatment adjusted to the strain of the index case. DISCUSSION: In the setting of emerging MDR-TB, tuberculin skin test may be likely replaced by specific interferon-gamma release assays (IGRA), independent of prior BCG vaccination. In addition, chest CT scan is preferred to chest X-ray to detect TB lesions. The management of latent TB infection is controversial: immediate treatment with second-line anti-TB drugs adapted to the index case strain or, consistently with WHO guidelines, a simple follow-up with subsequent treatment in case of active TB.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antituberculeux de seconde ligne; Antituberculosis preventive treatment; Enfants contacts; Infection tuberculeuse latente; Latent tuberculosis; Multidrug-resistant tuberculosis; Pediatric contact cases; Second-line antituberculosis drugs; Traitement préventif antituberculeux; Tuberculose multi-résistante

Mesh:

Substances:

Year:  2015        PMID: 26195117     DOI: 10.1016/j.pneumo.2015.05.003

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  3 in total

Review 1.  CT and 18F-FDG PET abnormalities in contacts with recent tuberculosis infections but negative chest X-ray.

Authors:  Soon Ho Yoon; Jin Mo Goo; Jae-Joon Yim; Takashi Yoshiyama; JoAnne L Flynn
Journal:  Insights Imaging       Date:  2022-07-07

Review 2.  A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.

Authors:  Jeffrey I Campbell; Thomas J Sandora; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2021-05

3.  Yield of facility-based verbal screening amongst household contacts of patients with multi-drug resistant tuberculosis in Pakistan.

Authors:  Ejaz Qadeer; Razia Fatima; Mahboob Ul Haq; Aashifa Yaqoob; Nang Thu Thu Kyaw; Safieh Shah; Mrinalini Das; Petros Isaakidis
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2017-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.